Nexol-E Brand names, Nexol-E Analogs
Nexol-E Brand Names Mixture
Nexol-E fda sheet
Nexol-E msds (material safety sheet)
Nexol-E Synthesis Reference
No information avaliable
Nexol-E Molecular Weight
Nexol-E Melting Point
Nexol-E H2O Solubility
Nexol-E Dosage Forms
As an ophthalmic it is used for the treatment of steroid responsive inflammatory conditions of the eye such as allergic conjunctivitis, uveitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, and selected infective conjunctivitides. As a nasal spray, used for the treatment and management of seasonal allergic rhinitis.
Loteprednol etabonate (LE) is a "soft" steroid belonging to a unique class of glucocorticoids. LE possesses a metabolically labile 17 beta-chloromethyl ester function which was designed in order to be hydrolyzed to an inactive carboxylic acid moiety. This inactive metabolite is more hydrophilic and is thus readily eliminated from the body. Loteprednol etabonate has good ocular permeation properties and good skin permeation properties similar to "hard" steroids. It is used as a topical agent for the treatment of steroid responsive inflammatory conditions of the eye such as allergic conjunctivitis, uveitis and iritis.
Very limited systemic absorption, but good absorption at the point of delivery.
Nexol-E side effects and Toxicity
Adverse effects include abnormal vision / blurring, burning on instillation, chemosis, discharge, dry eyes, epiphora, foreign body sensation, itching, injection, and photophobia.
Nexol-E Patient Information
Nexol-E Organisms Affected
Humans and other mammals